Martingale Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $228K | Sell |
35,000
-26,597
| -43% | -$173K | 0.01% | 743 |
|
|
2025
Q1 | $488K | Sell |
61,597
-9,800
| -14% | -$77.7K | 0.01% | 603 |
|
|
2024
Q4 | $905K | Buy |
71,397
+93
| +0.1% | +$1.18K | 0.02% | 496 |
|
|
2024
Q3 | $993K | Buy |
71,304
+6,219
| +10% | +$86.6K | 0.02% | 457 |
|
|
2024
Q2 | $897K | Buy |
65,085
+11,204
| +21% | +$154K | 0.02% | 469 |
|
|
2024
Q1 | $890K | Buy |
53,881
+20,137
| +60% | +$333K | 0.02% | 498 |
|
|
2023
Q4 | $493K | Buy |
33,744
+3,600
| +12% | +$52.6K | 0.01% | 616 |
|
|
2023
Q3 | $370K | Buy |
30,144
+102
| +0.3% | +$1.25K | 0.01% | 652 |
|
|
2023
Q2 | $359K | Sell |
30,042
-1,900
| -6% | -$22.7K | 0.01% | 668 |
|
|
2023
Q1 | $427K | Sell |
31,942
-100
| -0.3% | -$1.34K | 0.01% | 652 |
|
|
2022
Q4 | $690K | Buy |
+32,042
| New | +$690K | 0.01% | 560 |
|